| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/05/2006 | CN1756761A Target recognizing binding agents |
| 04/05/2006 | CN1756565A Compositions for the treatment of mycobacterial infections |
| 04/05/2006 | CN1756564A Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells |
| 04/05/2006 | CN1756560A Complement receptor 2 targeted complement modulators |
| 04/05/2006 | CN1249233C Surface proteins of chlamydia pneumoniae |
| 04/05/2006 | CN1249227C 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249085C Immunogenic but non-amyloidogenic synthetic peptides homologous to beta amyloid for induction of immune response to beta amyloid and amyloid deposits |
| 04/05/2006 | CA2479539A1 Recombinant adenylate cyclase / hiv-tat protein and therapeutic and diagnostic uses thereof |
| 04/04/2006 | USRE39057 Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same |
| 04/04/2006 | US7022821 Tumor Antigen Derived Gene-15 (TADG-15); a detectably labeled antibody specific for the TADG-15 protein which has a molecular size of 100 kDa and comprises CUB, LDLR and serine protease domains; useful in the diagnosis or treatment of breast and ovarian cancer in particular |
| 04/04/2006 | US7022820 Nucleotide sequences for use in the treatment and detection of tumor disorders |
| 04/04/2006 | US7022818 of given amino acid sequence; use as a target for drug screening of antagonists or agonists of said receptor; receptor can bind persephin |
| 04/04/2006 | US7022817 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders |
| 04/04/2006 | US7022816 Dopamine receptors and genes |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022492 Ecstasy haptens and immunogens |
| 04/04/2006 | US7022490 Myc-binding zinc finger proteins, their preparation and their use |
| 04/04/2006 | US7022489 Nucleotide sequences coding protein for use in the treatment of alzheimer's disease |
| 04/04/2006 | US7022486 Detection of preferential protein in sample; obtain sample containing target protein, evaluate immunogenicity of protein, incubate with antibodies, measure concentration protein |
| 04/04/2006 | US7022482 Deactivation antigen protein; anticancer agents; Aids therapy |
| 04/04/2006 | US7022323 Prevent infections using envelope glycoprotein; binding to antibody |
| 04/04/2006 | US7022322 Comprises ligand for human immunoglobulin for immunoapheresis, which mimicks sequence of an adrenergic receptor structure |
| 04/04/2006 | US7022309 Targeting molecule linked to an imaging agent |
| 04/04/2006 | CA2316755C Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors |
| 04/04/2006 | CA1341503C Molecular cloning and expression of human il-3 |
| 03/30/2006 | WO2006034292A2 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| 03/30/2006 | WO2006033843A2 Lanthanide-based substrates and methods for determining clostridial toxin activity |
| 03/30/2006 | WO2006033742A2 Engineered antibody fragment that irreversibly binds an antigen |
| 03/30/2006 | WO2006033675A2 Bacillus anthracis spore specific antobodies |
| 03/30/2006 | WO2006033413A1 Method of quantifying peptide |
| 03/30/2006 | WO2006033386A1 STABILIZED HUMAN IgG4 ANTIBODIES |
| 03/30/2006 | WO2006033368A1 METHOD OF DETECTING HEPATITIS B VIRUS s ANTIGEN |
| 03/30/2006 | WO2006032127A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp |
| 03/30/2006 | WO2006017538A9 Hk1-binding proteins |
| 03/30/2006 | WO2006015371A9 Humanized anti-cmet antagonists |
| 03/30/2006 | WO2006012451A3 Compositions and methods of use for mgd-csf in disease treatment |
| 03/30/2006 | WO2005120567A3 Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof |
| 03/30/2006 | WO2005118643A3 Antibodies to angiogenesis inhibiting domains of cd148 |
| 03/30/2006 | WO2005117973A3 Bispecific binding agents for modulating biological activity |
| 03/30/2006 | WO2005115458A3 Methods and compositions related to regulation of nucleo-cytoplasmic localization of e1 dna helicase in papillomaviruses |
| 03/30/2006 | WO2005113604A3 Methods for immunoglobulin purification |
| 03/30/2006 | WO2005111078A9 Anti-cea scfv-beta-lactamase contructs (cab molecules) in adept |
| 03/30/2006 | WO2005107802A3 Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
| 03/30/2006 | WO2005095460A3 Bi-specific antibodies for targeting cells involved in allergic-type reactions, compositions and uses thereof |
| 03/30/2006 | WO2005087811A3 Estrogen receptors and methods of use |
| 03/30/2006 | WO2005072112A3 Methods for producing and identifying multispecific antibodies |
| 03/30/2006 | WO2005048935A3 Methods of modulating immunity |
| 03/30/2006 | WO2005046573A3 Pro104 antibody compositions and methods of use |
| 03/30/2006 | WO2005030124A3 Antibodies to m-csf |
| 03/30/2006 | WO2004070012A3 Cell-killing molecules and methods of use thereof |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060069246 Tumor necrosis factor receptor related proteins Tango-63d and Tango-63e |
| 03/30/2006 | US20060069242 Neurotrophic factor receptor |
| 03/30/2006 | US20060069239 Epididymis-specific gene as potential contraceptive target |
| 03/30/2006 | US20060069054 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/30/2006 | US20060069025 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 03/30/2006 | US20060068495 Process of cell electrofusion |
| 03/30/2006 | US20060068480 Polypeptides and polypeptide analogues |
| 03/30/2006 | US20060068472 Compositions to ameliorate protein misfolding and aggregation |
| 03/30/2006 | US20060068471 Soluble zcytor 11 cytokine receptors |
| 03/30/2006 | US20060068470 Antifreeze proteins from basidiomy cetes |
| 03/30/2006 | US20060068466 Used in assays for the identification of new agents for anesthesia and analgesia |
| 03/30/2006 | US20060068465 useful researching on neuroplasticity and pathology of neurodegenerative disorders |
| 03/30/2006 | US20060068453 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 03/30/2006 | US20060068449 N-terminal and C-terminal markers in nascent proteins |
| 03/30/2006 | US20060068445 Novel soluble CD14 antigen |
| 03/30/2006 | US20060068444 Compositions and methods for detecting cyclic analogs of hPTH |
| 03/30/2006 | US20060068442 immunogens; tumor antigens; devoid of immunosuppressive domain; fusion proteins; immunotherapy |
| 03/30/2006 | US20060068441 Alternative pol kappa nucleotide and amino acid sequence and methods for using |
| 03/30/2006 | US20060068439 Ucp4 |
| 03/30/2006 | US20060068437 Meg-3 protein |
| 03/30/2006 | US20060068425 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| 03/30/2006 | US20060068423 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060068413 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060068411 diagnosis of cancer in patients, by determining the level of oncogene expression in blood and detecting mRNA encoded by polynucleotide in peripheral blood mononuclear cells; screening for moderators and gene expression inhibitors, used for treating cancers in vivo |
| 03/30/2006 | US20060068404 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060068386 Complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof |
| 03/30/2006 | US20060067941 Nanotubes for cancer therapy and diagnostics |
| 03/30/2006 | US20060067940 Monoclonal antibody or an antigen binding fragment that specifically binds amino acids of a West Nile virus E protein |
| 03/30/2006 | US20060067938 Methods for the treatment of osteoarthritis and compositions thereof |
| 03/30/2006 | US20060067936 IL-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses |
| 03/30/2006 | US20060067934 DNA sequences encoding tumor necrosis factor receptors; recombinant expression vectors |
| 03/30/2006 | US20060067932 Antagonists specific for denatured collagen and methods of using same |
| 03/30/2006 | US20060067931 Receptor for lysophosphatidylcholine in vascular endothelial cells and use thereof |
| 03/30/2006 | US20060067930 Polypeptide variants with altered effector function |
| 03/30/2006 | US20060067889 Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents |
| 03/30/2006 | US20060067885 ablating a targeted non-malignant B cell, comprising administering to a human subject having an immune disease an unconjugated monoclonal antibody (LL2 antibody) which binds to a marker that is specific for a B cell |
| 03/30/2006 | US20060067884 for radiolabeling proteins, peptides and ligands with therapeutic radioisotopes such that these radiolabeled agents may be administered directly to patients without the need for additional purification; for the treatment of cancer |
| 03/30/2006 | CA2798495A1 Plant cells and plants with increased tolerance to environmental stress |
| 03/30/2006 | CA2619256A1 Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover |
| 03/30/2006 | CA2581319A1 Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection |
| 03/30/2006 | CA2581102A1 Lanthanide-based substrates and methods for determining clostridial toxin activity |
| 03/30/2006 | CA2580981A1 Stabilized human igg4 antibodies |
| 03/30/2006 | CA2580965A1 Monoclonal antibodies to progastrin |
| 03/30/2006 | CA2580921A1 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| 03/30/2006 | CA2580620A1 Method of detecting hepatitis b virus s antigen |
| 03/30/2006 | CA2580103A1 Immunogenic composition for use in vaccination against staphylococcei |
| 03/30/2006 | CA2579905A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp |
| 03/30/2006 | CA2577815A1 Engineered antibody fragment that irreversibly binds an antigen |